These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7147920)

  • 21. Biliary lipid composition in normo- and hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary hyperlipoproteinemia and cardiovascular diseases in relation to age].
    Reuter W; Herrmann W; Starke I; Ries W
    Z Gesamte Inn Med; 1976 Dec; 31(23):991-4. PubMed ID: 1020403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personality features of ischemic heart disease patients with different types of hyperlipoproteinemia.
    Pritykina NY; Chernigovskaya SV; Krivoruchenko IV; Kruchinina NA; Kukui LM
    Hum Physiol; 1978; 4(5):698-702. PubMed ID: 757550
    [No Abstract]   [Full Text] [Related]  

  • 25. Early repolarization: normalization of the electrocardiogram with exercise as a clinically useful diagnostic feature.
    Spratt KA; Borans SM; Michelson EL
    J Invasive Cardiol; 1995 Oct; 7(8):238-42. PubMed ID: 10158115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fatty acid composition of plasma lipids in hyperlipidemia associated with ischemic heart disease].
    Zeman M; Zák A; Písaríková A
    Cas Lek Cesk; 1993 Mar; 132(6):178-82. PubMed ID: 8485757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Platelet aggregation in hyperlipoproteinemias].
    Calabrese S; Da Col PG; Giansante C; Morgante O; Cattin L
    Minerva Med; 1982 May; 73(22):1541-6. PubMed ID: 7088380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early and late (during 3 years) results of coronary bypass operation in patients with ischemic heart disease with moderate dyslipoproteinemia].
    Tepliakov AT; Aptekar' VD; Kalomin EIu; Garganeeva AA; Cherniavskiĭ AM; Lusta IV; Chernov VI; Karpov RS
    Ter Arkh; 1998; 70(12):35-8. PubMed ID: 10067248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension].
    Pogozheva AV; Martynova EA; Samsonov MA; Egorova NI; Ksenofontova EA; Gorozhanskaia EG
    Vopr Pitan; 1994; (4):40-2. PubMed ID: 7817530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physical work capacity of ischemic heart disease patients with various types of hyperlipoproteinemias].
    Zadionchenko VS; Kopalova SM
    Kardiologiia; 1980 Aug; 20(8):75-9. PubMed ID: 7412102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute coronary syndromes and other forms of coronary heart disease in the National Health Service, 1997-2001.
    Gíria J; Catarino J; Rocha E
    Rev Port Cardiol; 2004 Jun; 23(6):883-92. PubMed ID: 15376734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipoprotein patterns in ischemic heart disease.
    Cupta RC; Sharma SK; Gupta NC
    Indian Heart J; 1980; 32(5):296-302. PubMed ID: 7239548
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in the active body-mass ratio (fatty mass) in hyperlipoproteinemias as affected by a combined dietetic regimen].
    Naumova R; Khandzhiev S
    Vutr Boles; 1982; 21(4):80-3. PubMed ID: 7147923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular complications in primary hyperlipoproteinemias (HLP) with special reference to changes in the eye fundus].
    Schulze J; Graupner K; Haller H; Hanefeld M; Leonhardt W
    Z Gesamte Inn Med; 1979 May; 34(10):121-2. PubMed ID: 483917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electrocardiographic changes in a group of students and their relation to several risk factors].
    Mincu L; Ionescu-Tîrgovişte C; Dumitrescu C; Mironescu V; Cheţa D; Mihalache N; Georgescu M; Popa E; Síntu E; Constantinescu A; Stănescu J; Grigorescu M; Străchinariu R; Bruckner I; Dida C; Gaşpar G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(1):29-33. PubMed ID: 6125009
    [No Abstract]   [Full Text] [Related]  

  • 38. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
    Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrocardiographic Minnesota code findings predicting short-term mortality in asymptomatic subjects. The Italian RIFLE Pooling Project (Risk Factors and Life Expectancy).
    Menotti A; Seccareccia F
    G Ital Cardiol; 1997 Jan; 27(1):40-9. PubMed ID: 9199942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
    Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.